autologous dendritic cells
Sponsors
Stanford University, M.D. Anderson Cancer Center, Cedars-Sinai Medical Center, Clinica Universidad de Navarra, Universidad de Navarra, H. Lee Moffitt Cancer Center and Research Institute
Conditions
Advanced CancerBrain Stem GliomaDiffuse Intrinsic Pontine GliomaFollicular LymphomaGBMGlioblastomaGlioblastoma MultiformeLeukemia
Phase 1
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
TerminatedNCT00185874
Start: 2004-01-31End: 2007-10-31Target: 22Updated: 2010-01-13
Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines
TerminatedNCT00514189
Start: 2007-07-31End: 2009-12-31Updated: 2012-07-30
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
CompletedNCT00576641
Start: 2007-05-31End: 2012-04-30Updated: 2014-10-30
Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines
NCT02840123
Start: 2016-06-30End: 2019-03-31Target: 10Updated: 2018-03-02
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
Active, not recruitingNCT03546426
Start: 2019-12-12End: 2028-09-30Target: 18Updated: 2024-10-01
Phase 2
Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
CompletedNCT01006044
Start: 2009-10-31End: 2014-08-31Updated: 2014-09-03
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
CompletedNCT01347034
Start: 2011-01-31End: 2016-04-30Updated: 2016-05-23
Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma
CompletedNCT02677155
Start: 2016-01-31End: 2021-02-28Updated: 2021-03-01
Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
RecruitingNCT04115761
Start: 2019-06-06End: 2026-12-30Target: 24Updated: 2024-09-19